BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1748033)

  • 21. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of pantoprazole drug interactions in man: an updated review.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):243-62. PubMed ID: 8793611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs.
    Rogers JF; Nafziger AN; Bertino JS
    Am J Med; 2002 Dec; 113(9):746-50. PubMed ID: 12517365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of omeprazole and cimetidine on plasma diazepam levels.
    Andersson T; Andrén K; Cederberg C; Edvardsson G; Heggelund A; Lundborg P
    Eur J Clin Pharmacol; 1990; 39(1):51-4. PubMed ID: 2276389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of omeprazole and polyethylene glycol-400 on antipyrine elimination by the isolated perfused rat liver.
    Webster LK; Jones DB; Mihaly GW; Smallwood RA
    J Pharm Pharmacol; 1984 Jul; 36(7):470-2. PubMed ID: 6146695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cimetidine on microsomal drug metabolism in man.
    Puurunen J; Sotaniemi E; Pelkonen O
    Eur J Clin Pharmacol; 1980 Aug; 18(2):185-7. PubMed ID: 7428801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography.
    Imaoka S; Inoue K; Funae Y
    Arch Biochem Biophys; 1988 Aug; 265(1):159-70. PubMed ID: 3415241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of the in vitro interaction between lidocaine and premedications using human liver microsomes.
    Nagashima A; Tanaka E; Inomata S; Honda K; Misawa S
    J Clin Pharm Ther; 2005 Apr; 30(2):185-8. PubMed ID: 15811173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
    Sawada Y; Hanano M; Sugiyama Y; Iga T
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The screening of selected microorganisms for use as models of mammalian drug metabolism.
    Griffiths DA; Best DJ; Jezequel SG
    Appl Microbiol Biotechnol; 1991 Jun; 35(3):373-81. PubMed ID: 1367317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interethnic difference in omeprazole's inhibition of diazepam metabolism.
    Caraco Y; Tateishi T; Wood AJ
    Clin Pharmacol Ther; 1995 Jul; 58(1):62-72. PubMed ID: 7628184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omeprazole: pharmacokinetics and metabolism in man.
    Cederberg C; Andersson T; Skånberg I
    Scand J Gastroenterol Suppl; 1989; 166():33-40; discussion 41-2. PubMed ID: 2690330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Omeprazole and the cytochrome P450 system of the liver].
    Petersen KU
    Leber Magen Darm; 1993 Sep; 23(5):186-92. PubMed ID: 8412467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions involving cimetidine--mechanisms, documentation, implications.
    Greene W
    Q Rev Drug Metab Drug Interact; 1984; 5(1):25-51. PubMed ID: 6152350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of omeprazole on diazepam disposition in the rat: in vitro and in vivo studies.
    Zomorodi K; Houston JB
    Pharm Res; 1995 Nov; 12(11):1642-6. PubMed ID: 8592663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation.
    Lemahieu WP; Maes BD; Verbeke K; Vanrenterghem Y
    Kidney Int; 2005 Mar; 67(3):1152-60. PubMed ID: 15698457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of chronic ethanol feeding on cytochrome P-448- and P-450-mediated drug metabolism in the rat.
    Mitchell MC; Hoyumpa A; Schenker S; Patwardhan RV
    Biochem Pharmacol; 1982 Mar; 31(5):695-9. PubMed ID: 7082337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and metabolism of omeprazole in man.
    Regårdh CG
    Scand J Gastroenterol Suppl; 1986; 118():99-104. PubMed ID: 3460172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of lansoprazole.
    Landes BD; Petite JP; Flouvat B
    Clin Pharmacokinet; 1995 Jun; 28(6):458-70. PubMed ID: 7656504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.